X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (37) 37
immunotherapy (26) 26
melanoma (26) 26
cancer (24) 24
oncology (24) 24
humans (23) 23
ipilimumab (23) 23
female (19) 19
metastatic melanoma (17) 17
nivolumab (17) 17
immunology (15) 15
article (14) 14
care and treatment (13) 13
middle aged (12) 12
survival (12) 12
immune checkpoint (11) 11
metastasis (11) 11
adverse events (10) 10
lymphocytes (10) 10
lymphocytes t (10) 10
animals (9) 9
male (9) 9
mice (9) 9
neoplasms. tumors. oncology. including cancer and carcinogens (9) 9
pembrolizumab (9) 9
tumors (9) 9
adult (8) 8
cancer therapies (8) 8
dermatology (8) 8
patients (8) 8
aged (7) 7
analysis (7) 7
checkpoint inhibitors (7) 7
programmed cell death 1 receptor - antagonists & inhibitors (7) 7
therapy (7) 7
toxicity (7) 7
cd8 antigen (6) 6
complications and side effects (6) 6
expression (6) 6
immunity (6) 6
inflammation (6) 6
mice, inbred c57bl (6) 6
mutation (6) 6
neoplasms - drug therapy (6) 6
neoplasms - immunology (6) 6
research (6) 6
anti-ctla-4 (5) 5
antibodies, monoclonal - adverse effects (5) 5
antineoplastic agents - adverse effects (5) 5
case report (5) 5
cd8-positive t-lymphocytes - immunology (5) 5
chemical and pharmacologic phenomena (5) 5
ctla-4 blockade (5) 5
drug eruptions - pathology (5) 5
drug therapy (5) 5
health aspects (5) 5
immunotherapy - methods (5) 5
melanoma - drug therapy (5) 5
metastases (5) 5
radiotherapy (5) 5
treatment outcome (5) 5
usage (5) 5
abridged index medicus (4) 4
adoptive transfer (4) 4
anti-pd-1 (4) 4
antibody (4) 4
antineoplastic agents, immunological - therapeutic use (4) 4
antitumor immunity (4) 4
association (4) 4
biomarkers (4) 4
biopsy (4) 4
blockade (4) 4
cd8 t-cells (4) 4
cell biology (4) 4
clinical trials (4) 4
combined modality therapy (4) 4
ctla-4 (4) 4
ctla-4 antigen - antagonists & inhibitors (4) 4
diagnosis (4) 4
diarrhea (4) 4
drug eruptions - etiology (4) 4
immune response (4) 4
lymphocytes, tumor-infiltrating - immunology (4) 4
management (4) 4
medical research (4) 4
medicine (4) 4
melanoma - immunology (4) 4
pathology (4) 4
pd-1 (4) 4
pd-1 protein (4) 4
prognosis (4) 4
research article (4) 4
risk groups (4) 4
skin (4) 4
t cells (4) 4
vaccines, dna - immunology (4) 4
activation (3) 3
advanced melanoma (3) 3
antibodies (3) 3
antibodies, monoclonal - therapeutic use (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Arthritis & Rheumatology, ISSN 2326-5191, 04/2017, Volume 69, Issue 4, pp. 687 - 699
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2017, Volume 23, Issue 6, pp. 1388 - 1396
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. 2061 - 2064
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2018, Volume 24, Issue 11, pp. 1649 - 1654
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 5, p. e10436
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2019, Volume 68, Issue 4, pp. 553 - 561
Journal Article
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 02/2015, Volume 135, Issue 2, pp. 508 - 515
The management of melanoma has evolved owing to improved understanding of its molecular drivers. To augment the current understanding of the prevalence,... 
mutation | melanoma | NRAS | BRAF | TP53 | sequencing
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2019, Volume 20, Issue 11, pp. 1544 - 1555
IL-10 has anti-inflammatory and CD8+ T-cell stimulating activities. Pegilodecakin (pegylated IL-10) is a first-in-class, long-acting IL-10 receptor agonist... 
Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 10063 - 10063
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5_suppl, pp. 41 - 41
Journal Article